CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER'S EQUITY - USD ($)	Convertible Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Employee Advances	Treasury Stock	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2013	$ 422	$ 27,708	$ 27,166,147	$ (9,001)	$ (3,419,715)	$ (28,130,668)	$ (4,365,107)
Beginning Balance, Shares at Dec. 31, 2013	422,315	27,708,303			1,179,212
Stock-based compensation			830,518				830,518
Shares issued as pursuant to employment agreement, Amount		$ 20	10,626				10,646
Shares issued as pursuant to employment agreement, Shares		21,289
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount	$ 30		$ 279,350				279,380
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares	29,564
Contractual dividends on Series B convertible preferred stock						$ (298,918)	(298,918)
Warrants issued as debt discount in connection with notes payable			$ 36,000				36,000
Issuance of common stock and warrants for cash, Amount		$ 11,022	1,526,733				1,537,755
Issuance of common stock and warrants for cash, Shares		11,020,003
Imputed value of services contributed			$ 116,666				116,666
Change in fair value of collateral securing employee advances				$ 6,858			$ 6,858
Cashless exercise of warrants into common stock, Amount
Cashless exercise of warrants into common stock, Shares
Debt discount related to repricing of warrants in connection with notes payable
Net loss						$ (1,783,279)	$ (1,783,279)
Ending Balance, Amount at Dec. 31, 2014	$ 452	$ 38,750	$ 29,966,040	$ (2,143)	$ (3,419,715)	$ (30,212,865)	(3,629,481)
Ending Balance, Shares at Dec. 31, 2014	451,879	38,749,595			1,179,212
Stock-based compensation			320,366				320,366
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount	$ 32		$ 298,886				298,918
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares	31,633
Contractual dividends on Series B convertible preferred stock						$ (319,854)	(319,854)
Warrants issued as debt discount in connection with notes payable			$ 69,600				$ 69,600
Issuance of common stock and warrants for cash, Amount
Issuance of common stock and warrants for cash, Shares
Imputed value of services contributed
Change in fair value of collateral securing employee advances				$ 2,143			$ 2,143
Cashless exercise of warrants into common stock, Amount		$ 94	$ (94)
Cashless exercise of warrants into common stock, Shares		94,779
Debt discount related to repricing of warrants in connection with notes payable			1,800				$ 1,800
Net loss						$ (626,682)	(626,682)
Ending Balance, Amount at Dec. 31, 2015	$ 484	$ 38,844	$ 30,656,598		$ (3,419,715)	$ (31,159,401)	$ (3,883,190)
Ending Balance, Shares at Dec. 31, 2015	483,512	38,844,374			1,179,212